Bhagiradha Chemicals & Industries working capital

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
149.98×149.98×158.27×150.08×92.73×
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
128.90×128.90×116.41×105.60×81.91×
125.92×125.92×103.96×91.68×65.93×
152.96×152.96×170.72×164.00×108.71×
3.18×2.81×2.45×2.63×3.94×
0.52×0.52×0.58×0.80×1.27×
0.66×0.66×−3.81×1.88×0.31×
0.21×0.21×−1.43×0.80×0.18×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

BHAGCHEM₹194.00

Bhagiradha Chemicals & Industries Limited

· Chemicals
₹ CrorePeersNACLINDDHANUKAGSPCROPBHARATRASINSECTICIDIPLMOLPUNJABCHEMMcap ₹2,516 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)92.73150.08158.27149.98149.98
Receivable Days (DSO)81.91105.60116.41128.90128.90
Payable Days (DPO)65.9391.68103.96125.92125.92
Cash Conversion Cycle (days)108.71164.00170.72152.96152.96
Working Capital Turnover3.942.632.452.813.18
Asset Turnover1.270.800.580.520.52
Cash Conversion (CFO/Net Income)0.311.88-3.810.660.66
CFO/EBITDA0.180.80-1.430.210.21
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.